Telehealth advocates: HHS did its bit on expanding OUD treatment; DEA needs to step up

The latest stories trending on MedCity News.

Editor's Pick

Top Story Telehealth Advocates: HHS Has Done Its Bit on Expanding OUD Treatment; DEA Needs to Step Up HHS recently released a final rule that allows practitioners in Opioid Treatment Programs to start patients on methadone or buprenorphine via telehealth. However, the final rule does not apply to the broader range of providers, leading telehealth advocates to call for additional changes from the DEA. Sponsored Content How Physician Practices Can Boost Revenues with a Turnkey Weight Management Program Presented by Build My Health The webinar, scheduled for March 6 at 2pm ET and sponsored by Build My Health, will discuss several topics related to weight management including: an overview of GLP-1 weight loss medication, automation in a subscription-based weight management program, and the rise of provider-to-consumer (PTC) models. Learn how to help patients lose weight as well as opportunity to generate $250K+ in monthly recurring revenue!

Featured News

With the Rise of AI, What IP Disputes in Healthcare Are Likely to Emerge? Munck Wilson Mandala Partner Greg Howison shared his perspective on some of the legal ramifications around AI, IP, connected devices and the data they generate, in response to emailed questions. Brain-Computer Interface (BCI) Technology: Revolutionizing Healthcare with Brain-Controlled Technology From diagnostics to treatment methodologies, BCI technology can unravel new dimensions of understanding and intervention, fundamentally altering the landscape of patient care. FDA Approves Iovance Cancer Treatment, the First Cell Therapy for a Solid Tumor Iovance Biotherapeutics's Amtagvi is now the first FDA-approved treatment based on type of cell called a tumor-infiltrating lymphocyte. The regulatory nod in advanced melanoma also makes Amtagvi the first cell therapy approved for treating a solid tumor. MedCity FemFwd: What Male Birth Control Means for Women's Health In this episode, we're joined by Régine Sitruk-Ware, a distinguished scientist at the Population Council's Center for Biomedical Research (CBR), and Chelsea Polis, senior scientist of epidemiology at CBR. They talk about the effect upcoming male birth control products could have on women's health. These 3 Pieces of Wisdom Could Help Hospitals Avoid Failure When Adopting New Tech During a recent panel, three health system executives shared some of the most important lessons they've learned from the digital initiatives they've worked on in the past couple years. Some of their nuggets of wisdom included starting with a problem instead of a solution and being sure not to use financial ROI as the only metric for success.

Resources

Slaughtering Myths, Bad Practices and Sacred Cows in Healthcare In the first episode of Debunked: Slaughtering Myths, Bad Practices and Sacred Cows in Healthcare, co-hosts Arundhati Parmar and Samir Batra discuss bad billing practices related to Arundhati's foot fracture while Samir offers solutions to the problem. They also discuss the annual J.P. Morgan Healthcare Conference, drug pricing and a healthcare transaction between General Catalyst and Summa Health. Listen Now

MedCity News • PO Box 901 • New York, NY unsubscribe